Abiopharma

🔍 MANN JENNIFER K (Executive)

Company: COCA COLA CO (KO)

Report Date: 2026-06-08

Detailed Transactions and Holdings:

• Acquired 51,606 shares of Common Stock, $.25 Par Value at $59.485 per share (Direct)
  Date: 2026-06-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 259,006.00 | transaction_form_type: 4
• Sold 51,606 shares of Common Stock, $.25 Par Value at $79.457 per share (Direct)
  Date: 2026-06-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 207,400.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 48,394 shares of Common Stock, $.25 Par Value at $50.4383 per share (Direct)
  Date: 2026-06-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 255,794.00 | transaction_form_type: 4
• Sold 48,394 shares of Common Stock, $.25 Par Value at $79.4556 per share (Direct)
  Date: 2026-06-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 207,400.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Holds 0 shares of Common Stock, $.25 Par Value (Direct)
  Date: 2026-06-08 | Code: H | nature_of_ownership: By 401(k) Plan | shares_owned_after: 8,309.00 | Footnotes: F4
• Sold 51,606 shares of Employee Stock Option (Right to Buy) at $59.485 per share (Derivative)
  Date: 2026-06-08 | Code: M | Expires: 2030-02-20 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F5
• Sold 48,394 shares of Employee Stock Option (Right to Buy) at $50.4383 per share (Derivative)
  Date: 2026-06-08 | Code: M | Expires: 2031-02-18 | equity_swap_involved: 0 | shares_owned_after: 18,830.00 | transaction_form_type: 4 | Footnotes: F6
• Holds 9,323 shares of Hypothetical Shares (Derivative)
  Date: 2026-06-08 | Code: H | shares_owned_after: 9,323.00 | Footnotes: F7, F8, F8, F9

Footnotes:

• F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on March 6, 2026.
• F2: The price is the weighted average sale price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $79.15 to $79.88. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
• F3: The price is the weighted average sale price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $79.11 to $79.91. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
• F4: Shares credited to the reporting person's account under The Coca-Cola Company 401(k) Plan, as of June 8, 2026.
• F5: Options (with tax withholding right) granted on February 20, 2020 under The Coca-Cola Company 2014 Equity Plan. One-fourth of grant became exercisable on each of the first, second, third and fourth anniversaries of the grant date.
• F6: Options (with tax withholding right) granted on February 18, 2021 under The Coca-Cola Company 2014 Equity Plan. One-fourth of grant became exercisable on each of the first, second, third and fourth anniversaries of the grant date.
• F7: Each hypothetical share is equal to one share of common stock of The Coca-Cola Company.
• F8: There is no data applicable with respect to the hypothetical shares.
• F9: As of June 8, 2026.